SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Tenaya Therapeutics, Inc. (TNYA) News

Follow Tenaya Therapeutics, Inc. (TNYA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TNYA Asset equity Sector Markets 90 days 3 Last 0.2883 Updated Nov 04, 2026, 09:09 PM UTC Open live news feed Open TNYA chart & news
M Tenaya Therapeutics Reports Third-Quarter 2026 Results and Business Update Tenaya Therapeutics said it received FDA Regenerative Medicine Advanced Therapy designation for TN-401. EQUITY | Nov 04, 2026, 09:09 PM UTC L Tenaya Therapeutics to participate in September investor conferences Tenaya Therapeutics announced it will participate in upcoming September investor conferences. The company is a clinical-stage biotech focused on therapies targeting heart disease underlying causes. EQUITY | Sep 03, 2026, 08:37 PM UTC L TNYA - Tenaya Therapeutics to Participate in Upcoming September Investor Conferences TNYA - Tenaya Therapeutics to Participate in Upcoming September Investor Conferences EQUITY | Sep 03, 2026, 08:30 PM UTC L TNYA - Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update TNYA - Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update EARNINGS | Aug 05, 2026, 08:05 PM UTC